Donald J. Santel - Insider Trading & Ownership

Location
4362 24 Th Street, San Francisco, CA
Summary
The estimated net worth of Donald J. Santel is at least $216K dollars as of June 7, 2024. Donald J. Santel is the Director of Aerovate Therapeutics, Inc. and owns shares of Jade Biosciences, Inc. (JBIO) stock worth about $205K. Donald J. Santel is the Former Director of Surrozen, Inc./DE and owns shares of Surrozen, Inc./DE (SRZN) stock worth about $11.4K.
Signature
/s/ George A. Eldridge, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Donald J. Santel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
JBIO Jade Biosciences, Inc. Director $205K Jun 5, 2024
SRZN, SRZNW Surrozen, Inc./DE Former Director $11.4K Aug 11, 2021
OYST Oyster Point Pharma, Inc. Director Jan 3, 2023

Insider Transactions Reported by Donald J. Santel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.